Inmune Bio Inc (INMB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | INMB | TRVI | DSGN | ||
| Company | Inmune Bio Inc | Trevi Therapeutics Inc | Design Therapeutics Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 11.17 | 3.02 | 3.76 | ||
| High | 11.75 | 3.12 | 3.83 | ||
| Low | 11.12 | 2.98 | 3.65 | ||
| Last | 11.57 | 3.02 | 3.72 | ||
| Change | +0.44 | +0.01 | +0.07 | ||
| % Change | +3.95% | +0.33% | +1.92% | ||
| Volume | 124,700 | 26,700 | 173,900 | ||
| 20-Day Average Volume | 178,505 | 163,070 | 258,200 | ||
| Previous Close | 11.13 | 3.01 | 3.65 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 10.44 | 2.84 | 3.73 | ||
| 20-Day Raw Stochastic | 73.98% | 78.82% | 40.00% | ||
| 20-Day Relative Strength | 53.66% | 53.84% | 55.16% | ||
| Weighted Alpha | +16.21 | -17.04 | +29.20 | ||
| Today's Opinion | 48% Buy | 72% Buy | 72% Buy | ||
| Previous Opinion | 16% Buy | 72% Buy | 72% Buy | ||
| Last Month's Opinion | 24% Buy | 64% Buy | 56% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +2.48% since 04/26/24 | +8.63% since 04/26/24 | -1.59% since 04/26/24 | ||
| Low | 10.81 on 05/02/24 | 2.74 on 05/01/24 | 3.51 on 04/30/24 | ||
| High | 12.72 on 04/30/24 | 3.12 on 05/03/24 | 3.94 on 04/29/24 | ||
| 1-Month | |||||
| %Chg | +14.55% since 04/03/24 | -4.43% since 04/03/24 | +0.54% since 04/03/24 | ||
| Low | 8.30 on 04/19/24 | 2.35 on 04/17/24 | 3.45 on 04/10/24 | ||
| High | 12.72 on 04/30/24 | 3.25 on 04/04/24 | 4.13 on 04/17/24 | ||
| 3-Month | |||||
| %Chg | +4.42% since 02/02/24 | +117.27% since 02/02/24 | +56.30% since 02/02/24 | ||
| Low | 8.30 on 04/19/24 | 1.38 on 02/05/24 | 2.24 on 02/13/24 | ||
| High | 14.74 on 02/14/24 | 4.00 on 03/21/24 | 4.14 on 04/01/24 | ||
| 6-Month | |||||
| %Chg | +60.25% since 11/03/23 | +88.75% since 11/03/23 | +69.86% since 11/03/23 | ||
| Low | 6.63 on 11/13/23 | 0.97 on 11/27/23 | 1.96 on 11/10/23 | ||
| High | 14.74 on 02/14/24 | 4.00 on 03/21/24 | 4.14 on 04/01/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 210,609 | 212,714 | 210,161 | ||
| Shares Outstanding, K | 18,203 | 70,435 | 56,495 | ||
| Annual Sales | 160,000 | 0 | 0 | ||
| Annual Net Income | -30,010,000 | -29,070,000 | -66,860,000 | ||
| Last Quarter Sales | 30,000 | 0 | 0 | ||
| Last Quarter Net Income | -8,410,000 | -7,820,000 | -11,840,000 | ||
| 60-Month Beta | 1.92 | 0.91 | 1.83 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.47 on 03/28/24 | -0.08 on 03/20/24 | -0.21 on 03/19/24 | ||
| Latest Earnings Date | 05/01/24 | 05/07/24 | 05/14/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||